Page last updated: 2024-11-04

sulfadiazine and Vestibular Diseases

sulfadiazine has been researched along with Vestibular Diseases in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Vestibular Diseases: Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katholm, M1
Johnsen, NJ1
Siim, C1
Willumsen, L1

Other Studies

1 other study available for sulfadiazine and Vestibular Diseases

ArticleYear
Bilateral sudden deafness and acute acquired toxoplasmosis.
    The Journal of laryngology and otology, 1991, Volume: 105, Issue:2

    Topics: Acute Disease; Adolescent; Audiometry; Drug Therapy, Combination; Female; Hearing Loss, Sudden; Huma

1991